
Metzar 50mg Tablet ER
Marketer
Zivago Pharma Private Limited
Salt Composition
Metoprolol Succinate (50mg)
Overview Metzar 50mg Tablet ER
CardioBeta 50mg Extended-Release Tablets are classified as beta-adrenergic blockers. This medication treats hypertension (high blood pressure), angina pectoris (chest pain due to heart issues), and cardiac arrhythmias (irregular heartbeats). It also helps prevent migraines and reduces the risk of future strokes and myocardial infarctions. CardioBeta 50mg ER may be administered alone or in conjunction with other therapies. Dosage and frequency are tailored to your specific condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal effectiveness. Full therapeutic benefits may take several weeks to manifest, and long-term use is often necessary. Continued use is vital even in the absence of symptoms; discontinuation may exacerbate your condition. Common side effects, typically mild and transient, include fatigue, cephalgia (headache), depressive symptoms, diarrhea, skin rash, bradycardia (slow heart rate), dizziness, and nausea. Some individuals may experience dyspnea (shortness of breath) or hypotension (low blood pressure). To minimize adverse reactions, your physician will likely initiate treatment with a low dose, gradually increasing it as needed. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, inform your physician of any hepatic (liver) impairment. CardioBeta 50mg ER is generally unsuitable for patients with bradycardia, severe peripheral vascular disease, severe congestive heart failure, or hypotension. Pregnant or lactating women should consult their physician before use. Always seek medical counsel to determine the appropriateness of this medication for your individual needs. Regular blood pressure monitoring is essential to assess the medication's efficacy. Alcohol consumption should be limited due to potential exacerbation of certain side effects.
Primary Ingredients of Metzar 50mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Metzar 50mg Tablet ER
Managing angina pectoris (chest pain from heart disease)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Controlling hypertension (high blood pressure)|Preventing migraine headaches
Major Benefits of Metzar 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Metzar 50mg Extended-Release Tablets can be taken with or without food, but consistent timing is recommended. High-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, should be avoided when taking Metzar 50mg Extended-Release Tablets.
Common Side effects of Metzar 50mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metzar 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metzar 50mg Extended-Release tablet whole; do not crush, chew, or divide it. This medication can be taken with or without food, but consistency in timing is recommended. To maximize effectiveness, avoid consuming Metzar 50mg Tablet ER with meals high in fat, including those containing olive oil, nuts (like Brazil nuts), dark chocolate, butter, or meat.
How Metzar 50mg Tablet ER works:
Metzar 50mg Extended-Release tablets are a sustained-action beta-adrenergic antagonist targeting cardiac function. They reduce heart rate and improve the heart's pumping efficiency, enhancing circulatory performance.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metzar 50mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metzar 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your physician for advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metzar 50mg tablets appear to pose minimal breastfeeding risk. Available human data indicate negligible infant hazard.
DrivingUNSAFE
Extended-release Metzar 50mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if experiencing these side effects.
KidneySAFE IF PRESCRIBED
Metzar 50mg extended-release tablets can be used safely by individuals with kidney impairment. No alteration of the Metzar 50mg extended-release tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Metzar 50mg Extended-Release tablets cautiously. Dosage modification of Metzar 50mg Extended-Release tablets may be necessary; physician consultation is recommended.
What if you forget to take Metzar 50mg Tablet ER :
Should you forget a Metzar 50mg Extended-Release Tablet, take it immediately. If your next dose is imminent, however, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metzar 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Good Habits | No. |
| Type of Therapy | Heart |
